Physician profile
Mariam Saad
NPI 1861071722
$1,452.08
in general payments reported to CMS, 2019-2025
15 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.22 · 2022: $615 · 2023: $439 · 2024: $172 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $287.47 | 2021-2025 | |
| Genzyme Corporation | $204.64 | 2022-2025 | |
| Incyte Corporation | $175.98 | 2022-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $134.09 | 2022-2024 | Winlevi |
| Regeneron Healthcare Solutions, INC. | $129.68 | 2023-2025 | Dupixent |
| Glaxosmithkline, LLC. | $116.35 | 2022 | |
| Amgen INC. | $106.64 | 2023-2025 | Otezla, Otezla |
| Biofrontera INC. | $85.73 | 2023-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Novartis Pharmaceuticals Corporation | $62.44 | 2022-2023 | |
| Pfizer INC. | $46.43 | 2023-2024 | |
| Leo Pharma INC. | $28.60 | 2022 | |
| Lilly USA, LLC | $23.10 | 2023 | Olumiant, Taltz |
| Galderma Laboratories, L.P. | $20.86 | 2023 | |
| Botanix Sb INC | $16.53 | 2025 | Sofdra |
| Dermavant Sciences, INC. | $13.54 | 2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariam Saad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.